Barim Estela Maria, McLellan Kátia Cristina Portero, Ribeiro Rogério Silicani, Carvalho José Antonio Maluf de, Lindström Jaana, Tuomilehto Jaakko, Corrente José Eduardo, Murta-Nascimento Cristiane
Medical School, Universidade Estadual Paulista (UNESP) - Botucatu (SP), Brazil.
Texas Institute for Kidney and Endocrine Disorders - Lufkin (TX), United States of America.
Rev Bras Epidemiol. 2020 Jun 12;23:e200060. doi: 10.1590/1980-549720200060. eCollection 2020.
The Finnish Diabetes Risk Score (FINDRISC) is a tool that was initially developed to predict the risk of developing type 2 diabetes mellitus in adults. This tool is simple, quick to apply, non-invasive, and low-cost. The aims of this study were to perform a translation and cultural adaptation of the original version of FINDRISC into Brazilian Portuguese and to assess test-retest reliability.
This work was done following the ISPOR Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes Measures. Once the final Brazilian Portuguese version (FINDRISC-Br) was developed, the reliability assessment was performed using a non-random sample of 83 individuals attending a primary care health center. Each participant was interviewed by trained registered dieticians on two occasions with a mean interval of 14 days. The reliability assessment was performed by analyzing the level of agreement between the test-retest responses of FINDRISC-Br using Cohen's kappa coefficient and the intraclass correlation coefficient (ICC).
The steps of ISPOR guidelines were consecutively followed without major problems. Regarding the reliability assessment, the questionnaire as a whole presented adequate reliability (Cohen's kappa = 0.82, 95%CI 0.72 - 0.92 and ICC = 0.94, 95%CI 0.91 - 0.96).
FINDRISC was translated into Brazilian Portuguese and culturally adapted following standard procedures. FINDRISC-Br has thus become available for use and has potential as a screening tool in different Brazilian settings and applications.
芬兰糖尿病风险评分(FINDRISC)是一种最初用于预测成年人患2型糖尿病风险的工具。该工具简单、应用快速、非侵入性且成本低。本研究的目的是将FINDRISC的原始版本翻译成巴西葡萄牙语并进行文化调适,同时评估重测信度。
本研究遵循国际药物经济学与结果研究协会(ISPOR)关于患者报告结局测量翻译和文化调适过程的良好实践原则。最终确定巴西葡萄牙语版本(FINDRISC-Br)后,使用来自一家初级保健健康中心的83名个体的非随机样本进行信度评估。每位参与者由经过培训的注册营养师进行两次访谈,平均间隔14天。通过使用科恩kappa系数和组内相关系数(ICC)分析FINDRISC-Br重测反应之间的一致性水平来进行信度评估。
ISPOR指南的步骤得以顺利连续遵循。关于信度评估,问卷整体呈现出足够的信度(科恩kappa = 0.82,95%置信区间0.72 - 于0.92;ICC = 0.94,95%置信区间0.91 - 0.96)。
FINDRISC已按照标准程序翻译成巴西葡萄牙语并进行了文化调适。因此,FINDRISC-Br可供使用,并且在巴西不同的环境和应用中具有作为筛查工具的潜力。